Literature DB >> 26739108

ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells.

Yutaro Obara1, Ryusuke Nagasawa2, Wataru Nemoto2, Michael J Pellegrino3, Maho Takahashi4, Beth A Habecker3, Philip J S Stork4, Osamu Ichiyanagi5, Hiromi Ito5, Yoshihiko Tomita5, Kuniaki Ishii6, Norimichi Nakahata2.   

Abstract

Extracellular signal-regulated kinases (ERKs) play important roles in proliferation, differentiation and gene expression. In our previous study, we demonstrated that both ERK5 and ERK1/2 were responsible for neurite outgrowth and tyrosine hydroxylase (TH) expression in rat pheochromocytoma cells (PC12) (J Biol Chem 284, 23,564-23,573, 2009). However, the functional differences between ERK5 and ERK1/2 signaling in neural differentiation remain unclear. In the present study, we show that ERK5, but not ERK1/2 regulates TH levels in rat sympathetic neurons. Furthermore, microarray analysis performed in PC12 cells using ERK5 and ERK1/2-specific inhibitors, identified ankyrin repeat domain 1 (ankrd1) as an ERK5-dependent and ERK1/2-independent gene. Here, we report a novel role of the ERK5/ankrd1 signaling in regulating TH levels and catecholamine biosynthesis. Ankrd1 mRNA was induced by nerve growth factor in time- and concentration-dependent manners. TH levels were reduced by ankrd1 knockdown with no changes in the mRNA levels, suggesting that ankrd1 was involved in stabilization of TH protein. Interestingly, ubiquitination of TH was enhanced and catecholamine biosynthesis was reduced by ankrd1 knockdown. Finally, we examined the relationship of ERK5 to TH levels in human adrenal pheochromocytomas. Whereas TH levels were correlated with ERK5 levels in normal adrenal medullas, ERK5 was down-regulated and TH was up-regulated in pheochromocytomas, indicating that TH levels are regulated by alternative mechanisms in tumors. Taken together, ERK5 signaling is required for catecholamine biosynthesis during neural differentiation, in part to induce ankrd1, and to maintain appropriate TH levels. This pathway is disrupted in pathological conditions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ankyrin repeat domain 1 (ankrd1); Extracellular-signal regulated kinase (ERK); Nerve growth factor (NGF); Pheochromocytoma; Sympathetic neurons; Tyrosine hydroxylase (TH)

Mesh:

Substances:

Year:  2015        PMID: 26739108      PMCID: PMC6521842          DOI: 10.1016/j.cellsig.2015.12.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  Expression of Extracellular Signal-regulated Kinase 5 and Ankyrin Repeat Domain 1 in Composite Pheochromocytoma and Ganglioneuroblastoma Detected Incidentally in the Adult Adrenal Gland.

Authors:  Shinta Suenaga; Osamu Ichiyanagi; Hiromi Ito; Sei Naito; Tomoyuki Kato; Akira Nagaoka; Tomoya Kato; Mitsunori Yamakawa; Yutaro Obara; Norihiko Tsuchiya
Journal:  Intern Med       Date:  2016-12-15       Impact factor: 1.271

2.  Identification of candidate genetic variants and altered protein expression in neural stem and mature neural cells support altered microtubule function to be an essential component in bipolar disorder.

Authors:  Katarina Truvé; Toshima Z Parris; Dzeneta Vizlin-Hodzic; Susanne Salmela; Evelin Berger; Hans Ågren; Keiko Funa
Journal:  Transl Psychiatry       Date:  2020-11-09       Impact factor: 6.222

3.  Trojan Horse Delivery of 4,4'-Dimethoxychalcone for Parkinsonian Neuroprotection.

Authors:  Wenlong Zhang; Huaqing Chen; Liuyan Ding; Junwei Gong; Mengran Zhang; Wenyuan Guo; Pingyi Xu; Shiying Li; Yunlong Zhang
Journal:  Adv Sci (Weinh)       Date:  2021-03-03       Impact factor: 16.806

4.  Effect of Extracellular Signal-Regulated Protein Kinase 5 Inhibition in Clear Cell Renal Cell Carcinoma.

Authors:  Hidenori Kanno; Sei Naito; Yutaro Obara; Hiromi Ito; Osamu Ichiyanagi; Takafumi Narisawa; Tomoyuki Kato; Akira Nagaoka; Norihiko Tsuchiya
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

5.  Midnolin is a novel regulator of parkin expression and is associated with Parkinson's Disease.

Authors:  Yutaro Obara; Toru Imai; Hidenori Sato; Yuji Takeda; Takeo Kato; Kuniaki Ishii
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

6.  ERK5 Phosphorylates Kv4.2 and Inhibits Inactivation of the A-Type Current in PC12 Cells.

Authors:  Yurina Kashino; Yutaro Obara; Yosuke Okamoto; Takeo Saneyoshi; Yasunori Hayashi; Kuniaki Ishii
Journal:  Int J Mol Sci       Date:  2018-07-10       Impact factor: 5.923

7.  Midnolin is a confirmed genetic risk factor for Parkinson's disease.

Authors:  Yutaro Obara; Hidenori Sato; Takahiro Nakayama; Takeo Kato; Kuniaki Ishii
Journal:  Ann Clin Transl Neurol       Date:  2019-10-06       Impact factor: 4.511

Review 8.  Clinical Significance and Regulation of ERK5 Expression and Function in Cancer.

Authors:  Matilde Monti; Jacopo Celli; Francesco Missale; Francesca Cersosimo; Mariapia Russo; Elisa Belloni; Anna Di Matteo; Silvia Lonardi; William Vermi; Claudia Ghigna; Emanuele Giurisato
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.